EXAS•benzinga•
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
Summary
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 21, 2025 by benzinga